Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Thyrotropin suppression by metformin.

Robert A Vigersky1, Amy Filmore-Nassar, Allan R Glass

  • 1Endocrinology Service, Walter Reed, Army Medical Center, Washington, DC 20307, USA. robert.vigersky@na.amedd.army.mil

The Journal of Clinical Endocrinology and Metabolism
|October 13, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Glycemic Concordance of Simplera Sync<b>™</b> and Instinct<b>™</b> Sensors in MiniMed<b>™</b> 780G System Users: A Randomized Crossover Feasibility Study.

Diabetes technology & therapeutics·2026
Same author

Safety and Effectiveness of MiniMed™ 780G Advanced Hybrid Closed-Loop Use with Ultrarapid Insulin Lispro-AABC in Pediatric and Adult Type 1 Diabetes.

Diabetes technology & therapeutics·2026
Same author

MiniMed<sup><b>™</b></sup> 780G System Users Achieve Similar Glycemic Outcomes Regardless of Socioeconomic Disadvantage.

Diabetes technology & therapeutics·2026
Same author

Automated insulin delivery with the MiniMed™ 780G system reduces burden by improving sleep and glycaemic control overnight.

Diabetes, obesity & metabolism·2026
Same author

MiniMed 780G Advanced Hybrid Closed-Loop System Use During Days Without User-Initiated Boluses.

Diabetes care·2026
Same author

Automated basal insulin delivery versus multiple daily injections in type 1 diabetes: results from a randomized parallel controlled trial.

Frontiers in endocrinology·2026
Same journal

Genetic and Clinical Factors Associated With Metformin Plasma Concentrations Following an Acute Metformin Challenge.

The Journal of clinical endocrinology and metabolism·2026
Same journal

Continuous glucose monitoring-derived time in range is associated with changes in arterial stiffness in type 2 diabetes.

The Journal of clinical endocrinology and metabolism·2026
Same journal

Association of the Primary Aldosteronism Severity Classification with Lateralization and Treatment Outcomes.

The Journal of clinical endocrinology and metabolism·2026
Same journal

From Premature Adrenarche to Adult Metabolic Risk and Hyperandrogenism: A Systematic Review and Meta-Analysis.

The Journal of clinical endocrinology and metabolism·2026
Same journal

Open-Label 9-Year Follow-Up Extension Phase 2 Study of Once-Weekly Somatrogon in Children With Growth Hormone Deficiency.

The Journal of clinical endocrinology and metabolism·2026
Same journal

Correction to: "CAHQL: A Patient-Reported Outcome Instrument to Assess Health-Related Quality of Life in Congenital Adrenal Hyperplasia".

The Journal of clinical endocrinology and metabolism·2026
See all related articles

Metformin use in hypothyroid patients suppressed thyroid-stimulating hormone (TSH) levels without causing hyperthyroidism. This effect may offer new therapeutic options for thyroid cancer patients.

Area of Science:

  • Endocrinology
  • Pharmacology
  • Internal Medicine

Background:

  • Drug-induced alterations in thyroid hormone economy are not well-documented.
  • Metformin, a widely used antidiabetic drug, has not been previously reported to affect thyroid hormone levels.
  • Understanding potential drug interactions is crucial for patient safety and effective treatment.

Observation:

  • This study observed four patients with chronic hypothyroidism on stable levothyroxine (L-T4) therapy.
  • Metformin was initiated in these patients for conditions including diabetes mellitus and nonalcoholic steatohepatitis.
  • Thyroid hormone levels were monitored after metformin initiation.

Findings:

  • Initiation of metformin led to suppressed serum TSH levels in all four patients.

Related Experiment Videos

  • TSH suppression occurred without clinical or biochemical evidence of hyperthyroidism.
  • Free T4 and free T3 levels remained unchanged in the observed patients.

    • Implications:

    • The mechanism behind metformin-induced TSH suppression is currently unknown.
    • Further prospective studies are needed to confirm these findings.
    • Metformin's TSH-suppressing effect could potentially be beneficial as an adjunct therapy for thyroid cancer patients.